In its 10-K report, Iovance Biotherapeutics highlighted its commercialization efforts for Amtagvi, the first product within ...

AI Mobility provider Webus International, steel industry veteran Luda Technology, Chinese ad services provider LZ Technology and ...

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Phase 3 Ovarian Cancer Trial to Initiate in March 2025 Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial ...

Social media is connected with the experience of stress 1, and too much stress impairs our abilities to remember, switch ...

We must find a golden middle between nourishing our sense of connection with each other and learning to be comfortable when ...

Urinary tract infections (UTIs) are common in older adults due to age-related risk factors and can often cause symptoms that ...

For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...

Lifesci Capital issued their FY2024 earnings estimates for Tourmaline Bio in a research report issued on Monday, February 24th. Lifesci Capital analyst R. Katkhuda forecasts that the company will post ...

Q2 2025 Earnings Conference Call February 26, 2025 5:00 PM ETCompany ParticipantsSilviu Itescu - Chief Executive ...

It is well established that children are more vulnerable than adults to environmental insults such as pesticides, from ...

为探究压力弹性和情绪障碍的神经生物学机制，加拿大拉瓦尔大学的研究人员对星形胶质细胞大麻素受体 1（CB1）展开研究，发现其可促进压力弹性，该研究为相关疾病治疗提供新方向。